Miria Ricchetti

USPTO Granted Patents = 4 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

2 out of 4,897

Commissariat a L'energie Atomique Et Aux Energies Alternatives

patents

where one patent can have more than one assignee

Years Active: 2018-2023

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11566280 - Method, probe and kit for DNA in situ hybridization and use thereof (2023-01-31),

2. 11287433 - Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s) (2022-03-29),

3. 10338082 - Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s) (2019-07-02),

4. 9957555 - Method, probe and kit for DNA in situ hybridization and use thereof (2018-05-01),

Title: Miria Ricchetti: Innovator in DNA Research

Introduction

Miria Ricchetti is a prominent inventor based in Paris, France. She has made significant contributions to the field of molecular biology, particularly in the area of DNA research. With a total of 4 patents, her work focuses on innovative methods for detecting and analyzing genomic DNA.

Latest Patents

One of her latest patents is a method, probe, and kit for DNA in situ hybridization. This invention relates to detecting the initiation of replication events in genomic DNA within eukaryotic cells. The method involves contacting eukaryotic cells with a nucleotide probe that hybridizes with a target region in the DNA genome. This target region contains a nucleic acid sequence that remains RNA-free during transcription and replication. The invention also includes kits for carrying out in situ hybridization, which can be used in the detection of mitochondrial diseases, neoplastic diseases, or cancers. Another notable patent involves methods for investigating mitochondrial replication dysfunction in biological samples. This invention is particularly relevant for subjects susceptible to physiological aging or progeroid syndromes, such as Cockayne syndrome.

Career Highlights

Miria Ricchetti has worked with prestigious institutions, including the Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has significantly advanced the understanding of DNA and mitochondrial functions, contributing to the development of therapeutic methods against aging-related conditions.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Laurent Arnaud Chatre and Alain Sarasin. These partnerships have further enriched her research and innovation in the field.

Conclusion

Miria Ricchetti's contributions to DNA research and her innovative patents highlight her role as a leading inventor in molecular biology. Her work continues to impact the scientific community and offers potential advancements in medical research and therapies.

This text is generated by artificial intelligence and may not be accurate.